Blueprint Medicines Gross Profit 2014-2024 | BPMC

Blueprint Medicines gross profit for the twelve months ending September 30, 2024 was $0.421B, a 114.06% increase year-over-year.

  • Blueprint Medicines annual gross profit for 2023 was $0.237B, a 33.46% increase from 2022.
  • Blueprint Medicines annual gross profit for 2022 was $0.177B, a 14.86% increase from 2021.
  • Blueprint Medicines annual gross profit for 2021 was $0.154B, a 80.54% decline from 2020.

Blueprint Medicines Gross Profit 2014-2024 | BPMC

  • Blueprint Medicines annual gross profit for 2023 was $0.237B, a 33.46% increase from 2022.
  • Blueprint Medicines annual gross profit for 2022 was $0.177B, a 14.86% increase from 2021.
  • Blueprint Medicines annual gross profit for 2021 was $0.154B, a 80.54% decline from 2020.